Northern Trust
BNTX icon

Northern Trust’s BioNTech BNTX Stock Holding History

Northern Trust’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,247
Closed -$1.44M – 4455
2026
Q1 		$1.44M Buy
+16,247
New +$1.67M ﹤0.01% 3142
2024
Q3 		– Sell
-78,444
Closed -$6.3M – 4420
2024
Q2 		$6.3M Sell
78,444
-2,788
-3% -$255K ﹤0.01% 2265
2024
Q1 		$7.49M Sell
81,232
-265
-0.3% -$25.4K ﹤0.01% 2230
2023
Q4 		$8.6M Buy
+81,497
New +$8.21M ﹤0.01% 2162
2022
Q1 		– Sell
-22,370
Closed -$5.77M – 4758
2021
Q4 		$5.77M Sell
22,370
-20,990
-48% -$5.75M ﹤0.01% 2605
2021
Q3 		$11.8M Buy
+43,360
New +$13.8M ﹤0.01% 2160

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Northern Trust's BNTX Position: Q2 2026 in Review

Northern Trust sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 16,247 shares — an estimated $1.44M sold.

Northern Trust first reported a position in BNTX in Q3 2021 and held it in 6 quarters. The position peaked at $11.8M in Q3 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Northern Trust reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
  • Northern Trust sold 16,247 BioNTech shares in Q2 2026, an estimated $1.44M.
  • Northern Trust first reported a position in BioNTech in Q3 2021 and held it in 6 quarters.
  • Northern Trust's BioNTech position peaked at $11.8M in Q3 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.